Bespoke Extracts (BSPK) 10-Q 21 Jan 20 2019 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Nov. 30, 2019	Jan. 15, 2020
Document and Entity Information [Abstract]
Entity Registrant Name	Bespoke Extracts, Inc.
Entity Central Index Key	0001409197
Amendment Flag	false
Current Fiscal Year End Date	--08-31
Document Type	10-Q
Document Period End Date	Nov. 30, 2019
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2019
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Shell Company	false
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Common Stock, Shares Outstanding		110,389,621
Entity File Number	000-52759
Entity Interactive Data Current	Yes
Entity Incorporation, State or Country Code	NV

Condensed Balance Sheets

Condensed Balance Sheets - USD ($)	Nov. 30, 2019	Aug. 31, 2019
Current assets
Cash	$ 81,865	$ 10,343
Accounts receivable, net	3,636	6,452
Prepaid expense	11,500	17,637
Inventory, net	1,264	3,171
Total current assets	98,265	37,603
Domain names, net of amortization of $9,200 and $8,364, respectively	40,985	41,821
Total assets	139,250	79,424
Current liabilities
Accounts payable and accrued liabilities	151,077	111,056
Convertible notes - net of unamortized discounts $182,156 and $0, respectively	17,844
Total current liabilities	168,921	111,056
Commitments and contingencies (Note 6)
Stockholders' Deficit
Common stock, $0.001 par value: 800,000,000 authorized; 105,388,426 and 78,155,093 shares issued and outstanding as of November 30, 2019 and August 31, 2019, respectively	105,389	78,156
Additional paid-in capital	14,341,227	13,950,095
Common stock payable	76,000	76,000
Accumulated deficit	(14,552,288)	(14,135,883)
Total stockholders' deficit	(29,671)	(31,632)
Total liabilities and stockholders' deficit	139,250	79,424
Series A Convertible Preferred Stock [Member]
Stockholders' Deficit
Preferred Stock, value
Series B Convertible Preferred Stock[Member]
Stockholders' Deficit
Preferred Stock, value	$ 1

Condensed Balance Sheets (Paren

Condensed Balance Sheets (Parenthetical) - USD ($)	Nov. 30, 2019	Aug. 31, 2019
Net of amortization cost	$ 9,200	$ 8,364
Convertible debt, unamortized discounts	$ 182,156	$ 0
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized	50,000,000	50,000,000
Preferred stock, shares issued	1	0
Preferred stock, shares outstanding	1	0
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized	800,000,000	800,000,000
Common stock, shares issued	105,388,426	105,388,426
Common stock, shares outstanding	78,155,093	78,155,093
Series A Convertible Preferred Stock
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares issued
Preferred stock, shares outstanding
Preferred stock, designated shares	1,000	1,000
Series B Preferred Stock
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares issued	1	0
Preferred stock, shares outstanding	1	0
Preferred stock, designated shares	1	1

Condensed Statements of Operati

Condensed Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Nov. 30, 2019	Nov. 30, 2018
Income Statement [Abstract]
Sales	$ 1,739	$ 41,431
Cost of products sold	1,087	11,608
Gross Profit	652	29,823
Operating expenses:
Selling, general and administrative expenses	241,502	(4,078,341)
Professional fees	55,375	37,995
Consulting	101,500	55,500
Amortization expense	836	836
Total operating expenses	399,213	(3,984,010)
(Loss) / Income from operations	(398,561)	4,013,833
Other expense
Financing common share expense		(76,000)
Interest expense	(17,844)	(84,033)
Total other expense	(17,844)	(160,033)
(Loss) / Income before income tax	(416,405)	3,853,800
Provision for income tax
Net (Loss) / Income	$ (416,405)	$ 3,853,800
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING
Basic and Diluted	90,161,615	46,257,657
NET (LOSS) / INCOME PER COMMON SHARE OUTSTANDING
Basic and Diluted	$ 0	$ 0.08

Condensed Statements of Cash Fl

Condensed Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Nov. 30, 2019	Nov. 30, 2018
Cash flows from operating activities
Net (Loss) / Income	$ (416,405)	$ 3,853,800
Adjustments to reconcile net (loss) / income to net cash used in operating activities
Amortization expense	836	836
Amortization of debt discounts	17,844	66,033
Bad debt expense	2,981
Gain on forfeited unvested employee stock award (net of cash paid of $1,600)		(2,440,768)
Option and warrant expense	156,366	(1,801,526)
Common stock issued for services	40,500	120,000
Financing common share expense		76,000
Changes in operating assets and liabilities:
Accounts receivable	(165)	(1,950)
Inventory	1,906	13,421
Prepaid expense	6,137	(1,358)
Accounts payable and accrued liabilities	64,022	27,962
Net Cash used in operating activities	(125,978)	(87,550)
Cash flow from financing activities
Proceeds from the issuance of  convertible debt	100,000
Proceeds from exercise of warrants for cash		2,000
Repurchase of common stock	(27,500)
Sale of common stock	125,000	120,000
Net cash provided by financing activities	197,500	122,000
Net increase in cash and cash equivalents	71,522	34,450
Cash and cash equivalents at beginning of period	10,343	79,784
Cash and cash equivalents at end of period	81,865	114,234
Supplemental disclosure of cash flow information
Cash paid for interest
Cash paid for income taxes
Noncash investing and financing activities:
Discount due beneficial conversion feature	36,300
Stock issued with convertible debt	63,700
Preferred stock issued for the conversion of accrued salary	$ 24,000

Condensed Statements of Cash _2

Condensed Statements of Cash Flows (Parenthetical)	3 Months Ended
	Nov. 30, 2019USD ($)
Statement of Cash Flows [Abstract]
Gain on forfeited unvested employee stock award	$ 1,600

Condensed Statement of Stockhol

Condensed Statement of Stockholders Deficit - USD ($)	Series A Preferred Shares	Series B Preferred Shares	Common Shares Outstanding	APIC	Common Stock Payable	Accumulated Deficit	Total
Balance at Aug. 31, 2018			$ 42,903	$ 16,246,201		$ (16,716,644)	$ (427,540)
Balance, shares at Aug. 31, 2018			42,902,712
Preferred stock issued for the conversion of accrued salary
Sale of common stock			$ 2,000	118,000			120,000
Sale of common stock, shares			2,000,000
Forfeiture of stock issued through warrant exercise, net of cash paid			$ (16,000)	(2,424,768)			(2,440,768)
Forfeiture of stock issued through warrant exercise, net of cash paid, shares			(16,000,000)
Common stock issued for the exercise of warrants			$ 20,000	(18,000)			2,000
Common stock issued for the exercise of warrants, shares			20,000,000
Common stock issued for services			$ 1,000	119,000			120,000
Common stock issued for services, shares			1,000,000
Option and warrant expense				(1,801,526)			(1,801,526)
Financing common share expense					76,000		(76,000)
Net income loss						3,853,800	3,853,800
Balance at Nov. 30, 2018			$ 49,903	12,238,907	76,000	(12,862,844)	(498,034)
Balance, shares at Nov. 30, 2018			49,902,712
Balance at Aug. 31, 2018			$ 42,903	16,246,201		(16,716,644)	(427,540)
Balance, shares at Aug. 31, 2018			42,902,712
Balance at Aug. 31, 2019			$ 78,156	13,950,095	76,000	(14,135,883)	(31,632)
Balance, shares at Aug. 31, 2019			78,155,093
Preferred stock issued for the conversion of accrued salary		$ 1		23,999			24,000
Preferred stock issued for the conversion of accrued salary, shares		1
Sale of common stock			$ 20,833	104,167			125,000
Sale of common stock, shares			20,833,333
Common stock issued for services			$ 4,500	36,000			40,500
Common stock issued for services, shares			4,500,000
Warrant expense				156,366			156,366
Financing common share expense
Common stock issued with debt			$ 4,900	58,800			63,700
Common stock issued with debt, shares			4,900,000
Repurchase of common stock			$ (3,000)	(24,500)			(27,500)
Repurchase of common stock, shares			(3,000,000)
Beneficial conversion feature				36,300			36,300
Net income loss						(416,405)	(416,405)
Balance at Nov. 30, 2019			$ 105,389	$ 14,341,227	$ 76,000	$ (14,552,288)	$ (29,671)
Balance, shares at Nov. 30, 2019			105,388,426

Nature of Operations, Significa

Nature of Operations, Significant Accounting Policies and Going Concern	3 Months Ended
	Nov. 30, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
NATURE OF OPERATIONS, SIGNIFICANT ACCOUNTING POLICIES AND GOING CONCERN	1. NATURE OF OPERATIONS, SIGNIFICANT ACCOUNTING POLICIES AND GOING CONCERN Nature of Business Operations Bespoke Extracts, Inc. (the "Company") is a Nevada corporation focused on marketing and selling a proprietary line of premium, quality, all natural CBD products in the forms of tinctures, capsules, drops and edibles for the nutraceutical and veterinary markets, which it introduced in mid-2018. Produced using pure, all natural, zero-THC phytocannabinoid-rich ("PCR") hemp-derived isolate, the Company markets its products as dietary supplements through its retail ecommerce store found at www.bespokeextracts.com. In the future, the Company also intends to sell its products through wholesale channels. Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim information and with the instructions to Form 10-Q and Regulation S-K. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. In the opinion of management, all adjustments consisting of a normal and recurring nature considered necessary for a fair presentation have been included. Operating results for the three-month period ended November 30, 2019 may not necessarily be indicative of the results that may be expected for the year ending August 31, 2020. For further information, refer to the Company's financial statements and footnotes thereto included in the Annual Report on Form 10-K for the year ended August 31, 2019. Certain prior period amounts have been reclassified to conform to current period presentation. Going Concern The accompanying financial statements have been prepared assuming a continuation of the Company as a going concern. The Company had negative cash flows from operations, a working capital deficit and an accumulated deficit for the three months ended and as of November 30, 2019. This raises substantial doubt about our ability to continue as a going concern. The Company's ability to continue as a going concern is dependent upon the Company generating profitable operations in the future and/or obtaining the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. There is no assurance that this series of events will be satisfactorily completed. The accompanying financial statements do not contain any adjustments that may result from the outcome of this uncertainty. Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the accompanying financial statements and accompanying notes. Actual results could differ from those estimates. Cash and Cash Equivalents Cash and cash equivalents include all highly liquid investments with original maturities of three months or less at the time of purchase. At November 30, 2019 and August 31, 2019, the Company did not have any cash equivalents. Fair Value of Financial Instruments The carrying amounts of cash, accounts receivable, prepaid expenses and other assets, accounts payable, accrued liabilities and convertible note payable approximate their fair values as of November 30, 2019 and August 31, 2019, respectively, because of their short-term natures. Accounts Receivable Accounts receivable are recorded at fair value on the date revenue is recognized. The Company provides allowances for doubtful accounts for estimated losses resulting from the inability of its customers to repay their obligation. If the financial condition of the Company's customers were to deteriorate, resulting in an impairment of their ability to repay, additional allowances may be required. The Company provides for potential uncollectible accounts receivable based on specific customer identification and historical collection experience adjusted for existing market conditions. If market conditions decline, actual collection experience may not meet expectations and may result in decreased cash flows and increased bad debt expense. The policy for determining past due status is based on the contractual payment terms of each customer, which are generally net 30 or net 60 days. Once collection efforts by the Company and its collection agency are exhausted, the determination for charging off uncollectible receivables is made. At November 30, 2019 and August 31, 2019 the Company has recorded an allowance for doubtful accounts of $2,981 and $0, respectively. Inventory Inventories are stated at the lower of cost or net realizable value. Cost is determined by the first-in, first-out basis and net realizable value. Net realizable value is defined as sales price less cost of completion, disposition and transportation and a normal profit margin. As of November 30, 2019 and August 31, 2019, inventory amounted to $1,264 and $3,171, respectively, which consisted of finished goods. During the year ended August 31, 2019 the Company reserved $52,332 for slow moving inventory. No additional reserve was recorded during the three months ended November 30, 2019. Revenue Recognition Net revenue is measured based on the amount of consideration that we expect to receive, reduced by discounts and estimates for credits and returns (calculated based upon previous experience and management's evaluation). Outbound shipping charged to customers is recognized at the time the related merchandise revenues are recognized and are included in net revenues. Inbound and outbound shipping and delivery costs are included in cost of revenues. Net revenues exclude sales and other similar taxes collected from customers. Our products are sold through our online and telephonic channels. Revenue is recognized when control of the merchandise is transferred to the customer, which generally occurs upon shipment. Payment is typically due on the date of shipment. The Company offers a 14 day return policy on sales. Stock Option Plans Stock options and warrants issued to consultants and other non-employees as compensation for services provided to the Company are accounted for based on the fair value of the services provided or the estimated fair market value of the option or warrant, whichever is more reliably measurable in accordance with , , Compensation-Stock Compensation, Net Income / Loss per Share Basic income / loss per share amounts are computed based on net income / loss divided by the weighted average number of common shares outstanding. Diluted earnings per share reflect the potential dilution that could occur if potentially dilutive securities were exercised or converted to common stock. The dilutive effect of options and warrants and their equivalent is computed by application of the treasury stock method and the effect of convertible securities by the "if converted" method. Outstanding options, warrants and convertible debt were excluded from the calculation of diluted income / loss per share during the three months ended September 30, 2019 and September 30, 2018 because their inclusion would have been anti-dilutive. The effect of 3,450,000 warrants and 1,200,000 options is anti-dilutive for the three months end November 30, 2019. The effect of 3,490,000 warrants and 1,200,000 options is anti-dilutive for the three months ended November 30, 2018. Recent Accounting Pronouncements In February 2016, the FASB issued ASU 2016-02, Leases The adoption of ASU 2016-02 did not have an impact on our balance sheet, results of operations or balance sheets as we currently do not have any long term corporate office and equipment leases.

Asset Purchase Agreement

Asset Purchase Agreement	3 Months Ended
	Nov. 30, 2019
Offsetting [Abstract]
ASSET PURCHASE AGREEMENT	2. ASSET PURCHASE AGREEMENT On February 21, 2017, the Company purchased all right, title, interest and goodwill in or associated with certain domain names set forth in an asset purchase agreement for a total of $20,185 in cash and 200,000 shares of the Company’s common stock valued at $30,000. For the three months ended November 30, 2019 and November 30, 2018 amortization expense amounted to $836 and $836 respectively. The domain names are being amortized over a 15 year period.

Convertible Note Payable

Convertible Note Payable	3 Months Ended
	Nov. 30, 2019
Debt Disclosure [Abstract]
CONVERTIBLE NOTE PAYABLE	3. CONVERTIBLE NOTE PAYABLE On November 6, 2019, the Company entered into and closed a securities purchase agreement with an accredited investor, pursuant to which, the Company issued and sold to the investor an original issue discount convertible debenture (which was amended and restated on November 11, 2019) in the principal amount of $200,000, for a purchase price of $100,000, resulting in an original issue discount of $100,000. The Company also issued to the investor 4,900,000 shares of common stock valued at $63,700 ($0.013 per share). As amended, the debenture had a maturity date of August 1, 2020 and was convertible into shares of common stock of the Company at a conversion price of $0.006, provided that, if the Company failed to repay the debenture upon maturity, the conversion price would be reduced to $0.001 (subject to adjustment for stock splits, stock dividends and similar transactions) and the debenture would bear interest at the rate of 9% per year. The Company recorded beneficial conversion of $36,300 due to the conversion feature. The debenture could not be converted to common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company's outstanding common stock. The Company's obligation to repay the debenture upon maturity was secured by a security interest in the Company's URLs pursuant to a security agreement between the Company and the investor. As of November 30, 2019 the Company recorded a total of $17,844 of expense for the amortization of the original issue discount, beneficial conversion feature and the common stock issued to the note holder. The note was subsequently repaid (see note 8).

Equity

Equity	3 Months Ended
	Nov. 30, 2019
Equity [Abstract]
EQUITY	4. EQUITY Common Stock and Preferred Stock The Company has authorized capital of 800,000,000 shares of common stock with a par value of $0.001, and 50,000,000 shares of preferred stock with a par value of $0.001. 1,000 shares of preferred stock are designated as Series A Convertible Preferred Stock. No shares of Series A Preferred Stock are issued and outstanding as of November 30, 2019 and August 31, 2019, respectively . 1 share of preferred stock is designated Series B Preferred Stock. 1 share and 0 shares of Series B Preferred Stock are issued and outstanding as of November 30, 2019 and August 31, 2019, respectively. The Series B Preferred Stock has a stated value of $24,000 and entitles the holder to 51% of the total voting power of the Company's stockholders. The Company may, in its sole discretion, redeem the Series B Preferred Stock at any time for a redemption price equal to the stated value. The Series B Preferred does not provide the holder with any dividend rights or any liquidation rights, and is not convertible to common stock. On October 30, 2018, the Company entered into an employment agreement with Niquana Noel pursuant to which Ms. Noel will serve as the Company's Chief Executive Officer and president for a term of four years, unless earlier terminated pursuant to the terms of the employment agreement. Pursuant to the terms of the employment agreement, Ms. Noel's annual salary is $96,000 and she received a warrant to purchase up to 20,000,000 shares of the Company's common stock at an exercise price of $0.0001 per share. Ms. Noel exercised the warrant for $2,000 and was issued the 20,000,000 shares on October 31, 2018. The shares received upon the exercise of the warrants are subject to forfeiture over a service period of four years. See "Warrants" below. Pursuant to a securities purchase agreement entered into on June 6, 2018 the Company was obligated to issue additional shares of common stock if the Company sold common stock at a price lower than $0.10 per share (or common stock equivalents with an exercise price less than $0.10 per share) during the six month period following the closing of the purchase agreement, in which event the Company was required to issue additional shares to the purchaser for no additional consideration, such that the total number of common stock received by the purchaser will be equal to $50,000 divided by lower financing price. As of November 30, 2019 and August 31, 2019, the Company was obligated to issue 500,000 shares of common stock valued at $76,000. On October 3, 2019, the Company entered into a letter agreement with Niquana Noel, the Company's chief executive officer. Pursuant to the agreement, Ms. Noel exchanged $24,000 in accrued but unpaid compensation owed to her by the Company for one share of newly created Series B Preferred Stock of the Company. In connection with the letter agreement, on October 3, 2019, the Company filed a Certificate of Designation of Series B Preferred Stock with the Secretary of State of Nevada. Pursuant to the Certificate of Designation, the Company designated one share of its preferred stock as Series B Preferred Stock. See "Common Stock and Preferred Stock" above. On October 14, 2019, the Company entered into and closed a securities purchase agreement with an accredited investor pursuant to which the Company issued and sold to the investor 20,833,333 shares of common stock for a purchase price of $125,000. In November 2019, 3,000,000 shares of common stock were returned to the Company for cancellation and the Company paid $27,500 in connection with a settlement agreement. On November 6, 2019, the Company entered into and closed a securities purchase agreement with an accredited investor, pursuant to which, the Company issued and sold to the investor an original issue discount convertible debenture (which was amended and restated on November 11, 2019) in the principal amount of $200,000, for a purchase price of $100,000, resulting in an original issue discount of $100,000. The Company also issued to the investor 4,900,000 shares of common stock valued at $63,700, ($0.013 per share). See Note 3. Effective November 11, 2019, the Company issued 4,500,000 shares of common stock pursuant to a consulting agreement valued at $40,500 ($0.009 per share). Warrants On May 22, 2017, the Company entered into an employment agreement with Marc Yahr to serve as President and Chief Executive Officer of the Company for a term of three years, unless earlier terminated pursuant to the terms of the employment agreement. Pursuant to the terms of the employment agreement, Mr. Yahr received a warrant to purchase up to 20,000,000 shares of the Company's common stock at an exercise price of $0.0001 per share. The warrants were exercised in full on May 31, 2017; however, the 20,000,000 shares of the Company's common stock were not issued to Mr. Yahr until June 10, 2017. The shares received upon the exercise of the warrants were subject to forfeiture over a service period of three years. The fair value of the award was determined to be $10,998,105 which will be recognized as compensation expense over the three year service period. Effective October 30, 2018, Marc Yahr resigned from all positions with the Company including as President and Chief Executive Officer of the Company (except as director, which he resigned as on November 25, 2018). Pursuant to the agreement, Mr. Yahr agreed to return 80% of the warrant shares to the Company if he served as CEO of the Company pursuant to the terms and conditions of the employment agreement for a period of more than 12 months but less than 18 months. Therefore, 16,000,000 shares of common stock were forfeited to the Company, and the Company recognized a gain on the forfeited common shares of ($2,440,768) net of $1,600 paid by the Company during the three months ended November 30, 2018. As of November 30, 2018, $0 remains to be expensed over the remaining vesting period. On March 2, 2018 the Company entered into a management agreement with Global Corporate Management, LLC. Pursuant to this agreement, the Company agreed to pay $4,000 and to issue 150,000 common stock purchase warrants per month (an aggregate of 3,600,000 warrants) with an exercise price of $0.50, exercisable commencing six months after issuance for a period of 5 years. During the three months ended November 30, 2019 and 2018 the Company recognized a gain of ($3,378) and $(1,281,412), respectively due to a remeasurement of this nonemployee award. On April 16, 2018, the Company entered into a consulting agreement with Dr. David Hellman for marketing and promotion services. The term is 1 year with payment of 50,000 warrants each month to purchase common stock with an exercise price of $0.60. However, if the consultant generates more than $10,000 in monthly sales, the warrants will have an exercise price of $.30, and if the consultant generates more than $20,000 in monthly sales, the warrants may be exchanged in "cashless exercise". Additionally, the Company shall pay 10% of retail sales and 5% of wholesale sales. On July 11, 2018 the Company terminated the agreement. On August 1, 2018 the Company entered into a new consulting agreement with Dr. Hellman. The term is 1 year with payment of 60,000 warrants each month to purchase common stock with an exercise price of $0.60. The warrants may be exercised on a cashless basis. A total of $256,038 warrant expense in relation to this award was recognized during the year ended August 31, 2018. During the three months ended November 30, 2019 and 2018 the Company recognized a gain of ($2,084) and $(115,843), respectively due to a remeasurement of this nonemployee award. On October 30, 2018, the Company entered into an employment agreement with Niquana Noel pursuant to which Ms. Noel will serve as the Company's Chief Executive Officer and president for a term of four years, unless earlier terminated pursuant to the terms of the employment agreement. Pursuant to the terms of the employment agreement, Ms. Noel's annual salary is $96,000 and she received a warrant to purchase up to 20,000,000 shares of the Company's common stock at an exercise price of $0.0001 per share. Ms. Noel exercised the warrant and was issued the 20,000,000 shares on October 31, 2018. The fair value of this award was determined to be $2,598,138 of which $161,828 was recognized during the three months ended November 30, 2019 and $54,128 was recognized during the three months ended November 30, 2018. Unamortized expense at November 30, 2019 is $1,893,920 and as of August 31, 2019 is $2,055,748. The shares received upon the exercise of the warrants are subject to forfeiture over a service period of four years. The shares will be required to be returned to the Company as follows and the Company accounts for forfeitures when they occur: Ms. Noel would have been required to return 80% of the common stock to the Company if she was not serving as Chief Executive Officer of the Company pursuant to the terms and conditions of her employment agreement as of October 30, 2019 (the first anniversary of the employment agreement); Ms. Noel shall return 60% of the common stock to the Company if she is not serving as the Chief Executive Officer of the Company pursuant to the terms and conditions of the employment agreement as of the second anniversary of the employment agreement (October 30, 2020); Ms. Noel shall return 40% of the common stock to the Company if she is not serving as Chief Executive Officer of the Company pursuant to the terms and conditions of the employment agreement as of the third anniversary of the employment agreement (October 30, 2021); Ms. Noel shall return 20% of the common stock to the Company if she is not serving as the Chief Executive Officer of the Company pursuant to the terms and conditions of the employment agreement as of the fourth anniversary of the employment agreement (October 30, 2022); The following table summarizes the warrant activities during the three months ended November 30, 2019: Number of Weighted- Outstanding at August 31, 2019 3,330,000 $ 0.56 Granted 120,000 - Cancelled or expired - - Exercised - - Outstanding at November 30, 2019 3,450,000 $ 0.56 Exercisable at November 30, 2019 3,330,000 $ 0.52 Intrinsic value at November 30, 2019 $ - The fair value of the warrants was estimated using the Black-Scholes option pricing model and the following range of assumptions: Grant Date For the three month ended November 30, 2019 Risk-free interest rate at grant date 1.52% - 1.61% Expected stock price volatility 326% - 394% Expected dividend payout - Expected life (in years) 2.5 – 4.5 OPTIONS On July 26, 2017 the Company granted a nonemployee options to purchase 2,200,000 shares of common stock. The options have a three year term. 1,000,000 options were immediately exercisable on the date of issuance with an exercise price of $0.001 and the remaining 1,200,000 options vest over a period of four (4) semiannual installments or every six (6) months until July 26, 2019 at an exercise price of $1.00. As of November ,30, 2019 all the options were fully vested. During the three months ended November 30, 2018 the Company recognized a gain of $(368,831). Number of Weighted- Outstanding at August 31, 2019 1,200,000 $ 1.00 Granted - - Canceled or expired - - Exercised - - Outstanding at November 30, 2019 1,200,000 $ 1.00 Exercisable at November 30, 2019 1,200,000 $ 1.00 Intrinsic value at November 30, 2019 $ -

Related Party Transactions

Related Party Transactions	3 Months Ended
	Nov. 30, 2019
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	5. RELATED PARTY TRANSACTIONS On May 22, 2017, the Company entered into an employment agreement with Marc Yahr to serve as President and Chief Executive Officer of the Company for a term of three years, unless earlier terminated pursuant to the terms of the employment agreement. See Note 4. On October 30, 2018, the Company entered into an employment agreement with Niquana Noel pursuant to which Ms. Noel will serve as the Company's Chief Executive Officer and president for a term of four years, unless earlier terminated pursuant to the terms of the employment agreement. See Note 4.

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Nov. 30, 2019
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	6. COMMITMENTS AND CONTINGENCIES On April 16, 2018 the Company entered into a consulting agreement with Dr. David Hellman for marketing and promotion services. The term is 1 year with payment of 50,000 warrants to purchase common stock with an exercise price of $0.60. However, if the consultant generates more than $10,000 in monthly sales, the warrants will have an exercise price of $0.30, and if the consultant generates more than $20,000 in monthly sales, the warrants may be exchanged in "cashless exercise". Additionally, the Company agreed to pay to the consultant 10% of retail sales and 5% of wholesale sales. On July 11, 2018 the Company terminated the agreement. On August 1, 2018 the Company entered into a new consulting agreement with Dr. Hellman. The term is 1 year with payment of 60,000 warrants to purchase common stock with an exercise price of $0.60. The warrants may be exercised on a cashless basis. (See note 4). As of November 30, 2019 no commission have been earned under this agreement. Pursuant to a securities purchase agreement entered into on June 6, 2018 the Company was obligated to issue additional shares of common stock if the Company sold common stock at a price lower than $0.10 per share (or common stock equivalents with an exercise price less than $0.10 per share) during the six month period following the closing of the purchase agreement, in which event the Company was required to issue additional shares to the purchaser for no additional consideration, such that the total number of common stock received by the purchaser will be equal to $50,000 divided by lower financing price. As of November 30, 2019 and August 31, 2019 the Company was obligated to issue 500,000 shares of common stock valued at $76,000 which is included in the common stock payable in the accompanying balance sheet. On July 19, 2019 the Company entered into a non-binding preliminary term sheet with Cannasaver Corp. ("Cannasaver"). The term sheet contemplates that the Company will acquire Cannasaver for aggregate consideration of $25,000,000, 80% of which will be in the form of common stock of the Company, and the remaining 20% of which will be in cash, it being recognized that the Company will need to raise such funds from investors. The completion of this acquisition will be subject to entering into definitive agreements and the satisfaction of customary closing conditions, and there is no assurance such transaction will be completed. Cannasaver is partially owned by Lyle Hauser, who is a former significant stockholder of the Company and is an adviser to the Company. As of the date of this report the transaction has not been consummated.

Major Customers

Major Customers	3 Months Ended
	Nov. 30, 2019
Risks and Uncertainties [Abstract]
MAJOR CUSTOMERS	7. MAJOR CUSTOMERS There are concentrations of credit risk with respect to accounts receivables due to the amounts owed by one customer at August 31, 2019 whose balance represented approximately 28%, of total accounts receivables. As of November 30, 2019 no customer amounted to over 10% of accounts receivable. During the three months ended November 30, 2018, no individual customer amounted to over 10% of total sales. During the three months ended November 30, 2019 sales to one customer amounted to 67% of sales. The loss of business from one or a combination of the Company's significant customers, or an unexpected deterioration in their financial condition, could adversely affect the Company's operations.

Subsequent Events

Subsequent Events	3 Months Ended
	Nov. 30, 2019
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	8. SUBSEQUENT EVENTS On December 24, 2019, the Company entered into and closed a securities purchase agreement with an accredited investor, pursuant to which, the Company issued and sold to the investor an original issue discount convertible debenture in the principal amount of $500,000, for a purchase price of $300,000. The Company also issued to the investor 5,000,000 shares of common stock. The debenture matures April 30, 2020 and is convertible into shares of common stock of the Company at a conversion price of $0.001, except that, if the Company fails to repay the Debenture upon maturity, the conversion price will be reduced to $0.0004 (subject to adjustment for stock splits, stock dividends, and similar transactions) and the debenture will bear interest at the rate of 9% per year. The debenture may not be converted to common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company's outstanding common stock. The Company's obligation to repay the debenture upon maturity is secured by a security interest in the Company's inventory pursuant to a security agreement between the Company and the investor. On December 24, 2019, the Company entered into an agreement (the "Repayment Agreement") with the holder of the amended and restated original issue discount convertible debenture issued by the Company on November 11, 2019 (the "November 2019 Debenture"), in the original principal amount of $200,000 (see note 3). Pursuant to the Repayment Agreement, the Company paid the holder $120,000, and transferred certain URLs to the holder, and the November 2019 Debenture was deemed paid in full.

Nature of Operations, Signifi_2

Nature of Operations, Significant Accounting Policies and Going Concern (Policies)	3 Months Ended
	Nov. 30, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature of Business Operations	Nature of Business Operations Bespoke Extracts, Inc. (the "Company") is a Nevada corporation focused on marketing and selling a proprietary line of premium, quality, all natural CBD products in the forms of tinctures, capsules, drops and edibles for the nutraceutical and veterinary markets, which it introduced in mid-2018. Produced using pure, all natural, zero-THC phytocannabinoid-rich ("PCR") hemp-derived isolate, the Company markets its products as dietary supplements through its retail ecommerce store found at www.bespokeextracts.com. In the future, the Company also intends to sell its products through wholesale channels.
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim information and with the instructions to Form 10-Q and Regulation S-K. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. In the opinion of management, all adjustments consisting of a normal and recurring nature considered necessary for a fair presentation have been included. Operating results for the three-month period ended November 30, 2019 may not necessarily be indicative of the results that may be expected for the year ending August 31, 2020. For further information, refer to the Company's financial statements and footnotes thereto included in the Annual Report on Form 10-K for the year ended August 31, 2019. Certain prior period amounts have been reclassified to conform to current period presentation.
Going Concern	Going Concern The accompanying financial statements have been prepared assuming a continuation of the Company as a going concern. The Company had negative cash flows from operations, a working capital deficit and an accumulated deficit for the three months ended and as of November 30, 2019. This raises substantial doubt about our ability to continue as a going concern. The Company's ability to continue as a going concern is dependent upon the Company generating profitable operations in the future and/or obtaining the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. There is no assurance that this series of events will be satisfactorily completed. The accompanying financial statements do not contain any adjustments that may result from the outcome of this uncertainty.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the accompanying financial statements and accompanying notes. Actual results could differ from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents Cash and cash equivalents include all highly liquid investments with original maturities of three months or less at the time of purchase. At November 30, 2019 and August 31, 2019, the Company did not have any cash equivalents.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The carrying amounts of cash, accounts receivable, prepaid expenses and other assets, accounts payable, accrued liabilities and convertible note payable approximate their fair values as of November 30, 2019 and August 31, 2019, respectively, because of their short-term natures.
Accounts Receivable	Accounts Receivable Accounts receivable are recorded at fair value on the date revenue is recognized. The Company provides allowances for doubtful accounts for estimated losses resulting from the inability of its customers to repay their obligation. If the financial condition of the Company's customers were to deteriorate, resulting in an impairment of their ability to repay, additional allowances may be required. The Company provides for potential uncollectible accounts receivable based on specific customer identification and historical collection experience adjusted for existing market conditions. If market conditions decline, actual collection experience may not meet expectations and may result in decreased cash flows and increased bad debt expense. The policy for determining past due status is based on the contractual payment terms of each customer, which are generally net 30 or net 60 days. Once collection efforts by the Company and its collection agency are exhausted, the determination for charging off uncollectible receivables is made. At November 30, 2019 and August 31, 2019 the Company has recorded an allowance for doubtful accounts of $2,981 and $0, respectively.
Inventory	Inventory Inventories are stated at the lower of cost or net realizable value. Cost is determined by the first-in, first-out basis and net realizable value. Net realizable value is defined as sales price less cost of completion, disposition and transportation and a normal profit margin. As of November 30, 2019 and August 31, 2019, inventory amounted to $1,264 and $3,171, respectively, which consisted of finished goods. During the year ended August 31, 2019 the Company reserved $52,332 for slow moving inventory. No additional reserve was recorded during the three months ended November 30, 2019.
Revenue Recognition	Revenue Recognition Net revenue is measured based on the amount of consideration that we expect to receive, reduced by discounts and estimates for credits and returns (calculated based upon previous experience and management's evaluation). Outbound shipping charged to customers is recognized at the time the related merchandise revenues are recognized and are included in net revenues. Inbound and outbound shipping and delivery costs are included in cost of revenues. Net revenues exclude sales and other similar taxes collected from customers. Our products are sold through our online and telephonic channels. Revenue is recognized when control of the merchandise is transferred to the customer, which generally occurs upon shipment. Payment is typically due on the date of shipment. The Company offers a 14 day return policy on sales.
Stock Option Plans	Stock Option Plans Stock options and warrants issued to consultants and other non-employees as compensation for services provided to the Company are accounted for based on the fair value of the services provided or the estimated fair market value of the option or warrant, whichever is more reliably measurable in accordance with , , Compensation-Stock Compensation,
Net Income / Loss per Share	Net Income / Loss per Share Basic income / loss per share amounts are computed based on net income / loss divided by the weighted average number of common shares outstanding. Diluted earnings per share reflect the potential dilution that could occur if potentially dilutive securities were exercised or converted to common stock. The dilutive effect of options and warrants and their equivalent is computed by application of the treasury stock method and the effect of convertible securities by the "if converted" method. Outstanding options, warrants and convertible debt were excluded from the calculation of diluted income / loss per share during the three months ended September 30, 2019 and September 30, 2018 because their inclusion would have been anti-dilutive. The effect of 3,450,000 warrants and 1,200,000 options is anti-dilutive for the three months end November 30, 2019. The effect of 3,490,000 warrants and 1,200,000 options is anti-dilutive for the three months ended November 30, 2018.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In February 2016, the FASB issued ASU 2016-02, Leases The adoption of ASU 2016-02 did not have an impact on our balance sheet, results of operations or balance sheets as we currently do not have any long term corporate office and equipment leases.

Equity (Tables)

Equity (Tables)	3 Months Ended
	Nov. 30, 2019
Equity [Abstract]
Schedule of warrant activity and stock options	Number of Weighted- Outstanding at August 31, 2019 3,330,000 $ 0.56 Granted 120,000 - Cancelled or expired - - Exercised - - Outstanding at November 30, 2019 3,450,000 $ 0.56 Exercisable at November 30, 2019 3,330,000 $ 0.52 Intrinsic value at November 30, 2019 $ - Number of Weighted- Outstanding at August 31, 2019 1,200,000 $ 1.00 Granted - - Canceled or expired - - Exercised - - Outstanding at November 30, 2019 1,200,000 $ 1.00 Exercisable at November 30, 2019 1,200,000 $ 1.00 Intrinsic value at November 30, 2019 $ -
Schedule of fair value of the warrants was estimated using the Black-Scholes option pricing model	Grant Date For the three month ended November 30, 2019 Risk-free interest rate at grant date 1.52% - 1.61% Expected stock price volatility 326% - 394% Expected dividend payout - Expected life (in years) 2.5 – 4.5

Nature of Operations, Signifi_3

Nature of Operations, Significant Accounting Policies and Going Concern (Details) - USD ($)	3 Months Ended
	Nov. 30, 2019	Nov. 30, 2018	Aug. 31, 2019
Nature of Operations, Significant Accounting Policies and Going Concern (Textual)
Allowance for doubtful accounts	$ 2,981		$ 0
Inventory finished goods	$ 1,264		3,171
Inventory reserves			$ 52,332
Options [Member]
Nature of Operations, Significant Accounting Policies and Going Concern (Textual)
Anti-dilutive shares of warrants and options	1,200,000	1,200,000
Warrant [Member]
Nature of Operations, Significant Accounting Policies and Going Concern (Textual)
Anti-dilutive shares of warrants and options	3,450,000	3,490,000

Asset Purchase Agreement (Detai

Asset Purchase Agreement (Details) - USD ($)	3 Months Ended
	Nov. 30, 2019	Nov. 30, 2018	Feb. 21, 2017
Asset Purchase Agreement (Textual)
Total approximate amount include in asset purchase agreement			$ 20,185
Number of common stock			200,000
Common stock value			$ 30,000
Amortization expense	$ 836	$ 836
Amortized over period	15 years

Convertible Note Payable (Detai

Convertible Note Payable (Details) - USD ($)	Nov. 06, 2019	Nov. 30, 2019
Convertible Note Payable (Textual)
Securities purchase agreement, description	The Company entered into and closed a securities purchase agreement with an accredited investor, pursuant to which, the Company issued and sold to the investor an original issue discount convertible debenture (which was amended and restated on November 11, 2019) in the principal amount of $200,000, for a purchase price of $100,000, resulting in an original issue discount of $100,000. The Company also issued to the investor 4,900,000 shares of common stock valued at $63,700 ($0.013 per share). As amended, the debenture had a maturity date of August 1, 2020 and was convertible into shares of common stock of the Company at a conversion price of $0.006, provided that, if the Company failed to repay the debenture upon maturity, the conversion price would be reduced to $0.001 (subject to adjustment for stock splits, stock dividends and similar transactions) and the debenture would bear interest at the rate of 9% per year. The Company recorded beneficial conversion of $36,300 due to the conversion feature. The debenture could not be converted to common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company's outstanding common stock.
Amortization expense		$ 17,844

Equity (Details)

Equity (Details)	3 Months Ended
	Nov. 30, 2019USD ($)$ / sharesshares
Options [Member]
Class of Warrant or Right [Line Items]
Number of Warrants/Options, Outstanding Beginning balance	1,200,000
Number of Warrants/Options, Granted
Number of Warrants/Options, Cancelled or expired
Number of Warrants/Options, Exercised / Exchanged
Number of Warrants/Options, Outstanding Ending balance	1,200,000
Number of Warrants/Options, Exercisable	1,200,000
Weighted-Average Price Per Share, Outstanding Beginning balance | $ / shares	$ 1
Weighted-Average Price Per Share, Granted | $ / shares
Weighted-Average Price Per Share, Cancelled or expired | $ / shares
Weighted-Average Price Per Share, Exercised / Exchanged | $ / shares
Weighted-Average Price Per Share, Outstanding Ending balance | $ / shares	1
Weighted-Average Price Per Share, Exercisable | $ / shares	$ 1
Weighted-Average Price Per Share Intrinsic Value | $
Warrants [Member]
Class of Warrant or Right [Line Items]
Number of Warrants/Options, Outstanding Beginning balance	3,330,000
Number of Warrants/Options, Granted	120,000
Number of Warrants/Options, Outstanding Ending balance	3,450,000
Number of Warrants/Options, Exercisable	3,330,000
Weighted-Average Price Per Share, Outstanding Beginning balance | $ / shares	$ 0.56
Weighted-Average Price Per Share, Outstanding Ending balance | $ / shares	0.56
Weighted-Average Price Per Share, Exercisable | $ / shares	$ 0.52
Weighted-Average Price Per Share Intrinsic Value | $

Equity (Details 1)

Equity (Details 1) - Warrants [Member]	3 Months Ended
	Nov. 30, 2019
Class of Warrant or Right [Line Items]
Expected dividend payout
Minimum [Member]
Class of Warrant or Right [Line Items]
Risk-free interest rate at grant date	1.52%
Expected stock price volatility	326.00%
Expected option in life-years	2 years 6 months
Maximum [Member]
Class of Warrant or Right [Line Items]
Risk-free interest rate at grant date	1.61%
Expected stock price volatility	394.00%
Expected option in life-years	4 years 6 months

Equity (Details Textual)

Equity (Details Textual) - USD ($)

Nov. 06, 2019

Oct. 03, 2019

Oct. 30, 2018

Mar. 02, 2018

Nov. 11, 2019

Oct. 14, 2019

Oct. 31, 2018

Apr. 16, 2018

Jul. 26, 2017

May 22, 2017

Nov. 30, 2019

Nov. 30, 2018

Aug. 31, 2019

Equity (Textual)

Common stock, shares authorized

800,000,000

800,000,000

Common stock, par value

$ 0.001

$ 0.001

Preferred stock, shares authorized

50,000,000

50,000,000

Preferred stock, par value

$ 0.001

$ 0.001

Preferred stock, shares issued

1

0

Preferred stock, shares outstanding

1

0

Fair value of amortized discount

$ 836

$ 836

Warrant to purchase of common stock

20,000,000

Proceeds from exercise of warrants

2,000

Purchase agreement, description

The Company sold common stock at a price lower than $0.10 per share (or common stock equivalents with an exercise price less than $0.10 per share) during the six month period following the closing of the purchase agreement, in which event the Company was required to issue additional shares to the purchaser for no additional consideration, such that the total number of common stock received by the purchaser will be equal to $50,000 divided by lower financing price. As of November 30, 2019 and August 31, 2019, the Company was obligated to issue 500,000 shares of common stock valued at $76,000.

Unamortized expense

$ 1,893,920

1,893,920

$ 2,055,748

Proceeds of sale amount

125,000

120,000

Common stock issued value

63,700

Common stock for services, value

$ 40,500

$ 120,000

Series A Convertible Preferred Stock [Member]

Equity (Textual)

Preferred stock, par value

$ 0.001

$ 0.001

Preferred stock, designated shares

1,000

1,000

Preferred stock, shares issued

Preferred stock, shares outstanding

Series B Preferred Stock [Member]

Equity (Textual)

Preferred stock, par value

$ 0.001

$ 0.001

Preferred stock, designated shares

1

1

Preferred stock, shares issued

1

0

Preferred stock, shares outstanding

1

0

Preferred stock stated value

$ 24,000

Holder voting power, description

The holder to 51% of the total voting power of the Company’s stockholders.

Ms. Noel shall [Member]

Equity (Textual)

Common stock, description

Ms. Noel would have been required to return 80% of the common stock to the Company if she was not serving as Chief Executive Officer of the Company pursuant to the terms and conditions of her employment agreement as of October 30, 2019

Unpaid compensation

$ 24,000

Ms. Noel shall One [Member]

Equity (Textual)

Common stock, description

Ms. Noel shall return 60% of the common stock to the Company if she is not serving as the Chief Executive Officer of the Company pursuant to the terms and conditions of the employment agreement as of the second anniversary of the employment agreement (October 30, 2020);

Ms. Noel shall Two [Member]

Equity (Textual)

Common stock, description

Ms. Noel shall return 40% of the common stock to the Company if she is not serving as Chief Executive Officer of the Company pursuant to the terms and conditions of the employment agreement as of the third anniversary of the employment agreement (October 30, 2021);

Ms. Noel shall Three [Member]

Equity (Textual)

Common stock, description

Ms. Noel shall return 20% of the common stock to the Company if she is not serving as the Chief Executive Officer of the Company pursuant to the terms and conditions of the employment agreement as of the fourth anniversary of the employment agreement (October 30, 2022);

Investor [Member]

Equity (Textual)

Aggregate common stock shares issued

20,833,333

Aggregate common stock value

$ 125,000

Warrant [Member]

Equity (Textual)

Issuance of options

120,000

Convertible debt, description

Pursuant to the agreement, Mr. Yahr agreed to return 80% of the warrant shares to the Company if he served as CEO of the Company pursuant to the terms and conditions of the employment agreement for a period of more than 12 months but less than 18 months. Therefore, 16,000,000 shares of common stock were forfeited to the Company, and the Company recognized a gain on the forfeited common shares of ($2,440,768) net of $1,600 paid by the Company during the three months ended November 30, 2018. As of November 30, 2018, $0 remains to be expensed over the remaining vesting period.

Common Stock [Member]

Equity (Textual)

Shares of common stock forfeited

16,000,000

Sale of shares common stock

20,833,333

2,000,000

Proceeds of sale amount

$ 20,833

$ 2,000

Common stock issued value

$ 4,900

Common stock shares issued

4,900,000

Common stock, description

The Company issued 4,500,000 shares of common stock pursuant to a consulting agreement valued at $40,500 ($0.009 per share).

3,000,000 shares of common stock were returned to the Company for cancellation and the Company paid $27,500 in connection with a settlement agreement.

Common stock for services, shares

4,500,000

1,000,000

Common stock for services, value

$ 4,500

$ 1,000

Non Employee Stock Option [Member]

Equity (Textual)

Issuance of options

2,200,000

Options Exercised

1,000,000

Company recognized expense

(368,831)

Options exercise price

$ 0.001

Options vested shares

1,200,000

Options vested shares, exercise price

$ 1

President [Member]

Equity (Textual)

Warrant to purchase of common stock

20,000,000

Common stock per share price

$ 0.0001

Fair value of warrants

$ 10,998,105

Terms of warrants

3 years

Compensation expense recognized over service period

3 years

Chief Executive Officer [Member] | Warrant [Member]

Equity (Textual)

Shares of common stock forfeited

20,000,000

Chief Executive Officer [Member] | Common Stock [Member]

Equity (Textual)

Warrant to purchase of common stock

20,000,000

20,000,000

Common stock per share price

$ 0.0001

Proceeds from exercise of warrants

$ 2,000

Annual salary

$ 96,000

Global Corporate Management, LLC [Member]

Equity (Textual)

Warrant to purchase of common stock

150,000

Common stock per share price

$ 0.50

Terms of warrants

5 years

Company recognized expense

$ (3,378)

(1,281,412)

Aggregate common stock shares issued

4,000

Global Corporate Management, LLC [Member] | Warrant [Member]

Equity (Textual)

Warrant to purchase of common stock

3,600,000

Employment Agreement [Member]

Equity (Textual)

Purchase agreement, description

Niquana Noel pursuant to which Ms. Noel will serve as the Company’s Chief Executive Officer and president for a term of four years, unless earlier terminated pursuant to the terms of the employment agreement. Pursuant to the terms of the employment agreement, Ms. Noel’s annual salary is $96,000 and she received a warrant to purchase up to 20,000,000 shares of the Company’s common stock at an exercise price of $0.0001 per share. Ms. Noel exercised the warrant and was issued the 20,000,000 shares on October 31, 2018. The fair value of this award was determined to be $2,598,138 of which $161,828 was recognized during the three months ended November 30, 2019 and $54,128 was recognized during the three months ended November 30, 2018.

Consulting Agreement [Member] | Dr. David Hellman [Member]

Equity (Textual)

Warrant to purchase of common stock

50,000

Common stock per share price

$ 0.60

Terms of warrants

1 year

Company recognized expense

$ (2,084)

$ (115,843)

Consulting agreement, description

If the Consultant generates more than $10,000 in monthly sales, the Warrants will have an exercise price of $.30, and if the Consultant generates more than $20,000 in monthly sales, the Warrants may be exchanged in “cashless exercise”. Additionally, the Company shall pay 10% of retail sales and 5% of wholesale sales. On July 11, 2018 the Company terminated the agreement. On August 1, 2018 the Company entered into a new consulting agreement with Dr. Hellman. The term is 1 year with payment of 60,000 warrants each month to purchase common stock with an exercise price of $0.60. The warrants may be exercised on a cashless basis. A total of $256,038 warrant expense in relation to this award was recognized during the year ended August 31, 2018.

Securities Purchase Agreement [Member]

Equity (Textual)

Purchase agreement, description

The Company entered into and closed a securities purchase agreement with an accredited investor, pursuant to which, the Company issued and sold to the investor an original issue discount convertible debenture (which was amended and restated on November 11, 2019) in the principal amount of $200,000, for a purchase price of $100,000, resulting in an original issue discount of $100,000. The Company also issued to the investor 4,900,000 shares of common stock valued at $63,700, ($0.013 per share).

Common stock shares issued

500,000

500,000

Related Party Transactions (Det

Related Party Transactions (Details)	Oct. 30, 2018	May 22, 2017
Employment Agreement [Member]
Related Party Transactions (Textual)
Employment agreement, description	The Company entered into an employment agreement with Niquana Noel pursuant to which Ms. Noel will serve as the Company's Chief Executive Officer and president for a term of four years, unless earlier terminated pursuant to the terms of the employment agreement.
Chief Executive Officer [Member] | Warrant [Member]
Related Party Transactions (Textual)
Employment agreement, description		The Company entered into an employment agreement with Marc Yahr to serve as President and Chief Executive Officer of the Company for a term of three years, unless earlier terminated pursuant to the terms of the employment agreement.

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($)	Jun. 06, 2018	Jul. 19, 2019	Apr. 16, 2018	Nov. 30, 2019	Nov. 30, 2018	Aug. 31, 2019	Aug. 01, 2018	May 22, 2017
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]
Warrant to purchase of common stock								20,000,000
Monthly service received				$ 1,087	$ 11,608
Cannasaver Corp. [Member]
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]
Consideration price		$ 25,000,000
Cannasaver Corp. [Member] | Maximum [Member]
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]
Consideration percentage		80.00%
Cannasaver Corp. [Member] | Minimum [Member]
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]
Consideration percentage		20.00%
Securities Purchase Agreement [Member]
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]
Payments to issue of common stock				$ 76,000		$ 76,000
Exercise price	$ 0.10
Dividend	$ 50,000
Additional shares of common stock				500,000		500,000
Consulting Agreement [Member] | Dr David Hellman [Member]
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]
Common stock per share price			$ 0.60				$ 0.60
Warrant to purchase of common stock			50,000				60,000
Terms of warrants			1 year
Consulting agreement, description			However, if the consultant generates more than $10,000 in monthly sales, the warrants will have an exercise price of $0.30, and if the consultant generates more than $20,000 in monthly sales, the warrants may be exchanged in "cashless exercise". Additionally, the Company agreed to pay to the consultant 10% of retail sales and 5% of wholesale sales.

Major Customers (Details)

Major Customers (Details) - Customers	3 Months Ended		12 Months Ended
	Nov. 30, 2019	Nov. 30, 2018	Aug. 31, 2019
Sales [Member]
Major Customers (Textual)
Concentrations of credit risk	67.00%	10.00%
Number of Customers	1
Accounts Receivable [Member]
Major Customers (Textual)
Concentrations of credit risk	10.00%		28.00%
Number of Customers			1

Subsequent Events (Details)

Subsequent Events (Details) - Subsequent Event [Member]	1 Months Ended
	Dec. 24, 2019USD ($)
Subsequent Events (Textual)
Settlement agreement, description	The Company entered into and closed a securities purchase agreement with an accredited investor, pursuant to which, the Company issued and sold to the investor an original issue discount convertible debenture in the principal amount of $500,000, for a purchase price of $300,000. The Company also issued to the investor 5,000,000 shares of common stock. The Debenture matures April 30, 2020 and is convertible into shares of common stock of the Company at a conversion price of $0.001, except that, if the Company fails to repay the Debenture upon maturity, the conversion price will be reduced to $0.0004 (subject to adjustment for stock splits, stock dividends, and similar transactions) and the Debenture will bear interest at the rate of 9% per year. The Debenture may not be converted to common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company's outstanding common stock.
Original principal amount	$ 200,000
Convertible debenture,description	Pursuant to the Repayment Agreement, the Company paid the holder $120,000, and transferred certain URLs to the holder, and the November 2019 Debenture was deemed paid in full.